232 related articles for article (PubMed ID: 15858149)
1. c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation.
Yanagihori H; Oyama N; Nakamura K; Kaneko F
J Mol Diagn; 2005 May; 7(2):252-7. PubMed ID: 15858149
[TBL] [Abstract][Full Text] [Related]
2. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.
Bodemer C; Hermine O; Palmérini F; Yang Y; Grandpeix-Guyodo C; Leventhal PS; Hadj-Rabia S; Nasca L; Georgin-Lavialle S; Cohen-Akenine A; Launay JM; Barete S; Feger F; Arock M; Catteau B; Sans B; Stalder JF; Skowron F; Thomas L; Lorette G; Plantin P; Bordigoni P; Lortholary O; de Prost Y; Moussy A; Sobol H; Dubreuil P
J Invest Dermatol; 2010 Mar; 130(3):804-15. PubMed ID: 19865100
[TBL] [Abstract][Full Text] [Related]
3. C-kit Asp-816-Val mutation analysis in patients with mastocytosis.
Verzijl A; Heide R; Oranje AP; van Schaik RH
Dermatology; 2007; 214(1):15-20. PubMed ID: 17191042
[TBL] [Abstract][Full Text] [Related]
4. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.
Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J
J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847
[TBL] [Abstract][Full Text] [Related]
5. Genotype and phenotype analysis of patients with pediatric cutaneous mastocytosis, especially wild-type KIT patients.
Arase N; Wataya-Kaneda M; Murota H; Nakagawa Y; Yamaoka T; Itoi-Ochi S; Hirayasu K; Arase H; Fujimoto M; Katayama I
J Dermatol; 2020 Apr; 47(4):426-429. PubMed ID: 32077120
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous mastocytosis].
Flageul B
Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
[TBL] [Abstract][Full Text] [Related]
7. Identification of KIT activating mutations in paediatric solitary mastocytoma.
Ma D; Stence AA; Bossler AB; Hackman JR; Bellizzi AM
Histopathology; 2014 Jan; 64(2):218-25. PubMed ID: 24128084
[TBL] [Abstract][Full Text] [Related]
8. Nodular mastocytosis.
Kasprowicz S; Chan IJ; Wall DJ; Tharp MD
J Am Acad Dermatol; 2006 Aug; 55(2):347-9. PubMed ID: 16844528
[TBL] [Abstract][Full Text] [Related]
9. Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis.
Wasag B; Niedoszytko M; Piskorz A; Lange M; Renke J; Jassem E; Biernat W; Debiec-Rychter M; Limon J
Exp Hematol; 2011 Aug; 39(8):859-65.e2. PubMed ID: 21689725
[TBL] [Abstract][Full Text] [Related]
10. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.
Zappulla JP; Dubreuil P; Desbois S; Létard S; Hamouda NB; Daëron M; Delsol G; Arock M; Liblau RS
J Exp Med; 2005 Dec; 202(12):1635-41. PubMed ID: 16352739
[TBL] [Abstract][Full Text] [Related]
11. Familial urticaria pigmentosa: report of a family and review of the role of KIT mutations.
Fett NM; Teng J; Longley BJ
Am J Dermatopathol; 2013 Feb; 35(1):113-6. PubMed ID: 22892471
[TBL] [Abstract][Full Text] [Related]
12. Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis.
Chan IJ; Tharp MD
Clin Exp Dermatol; 2018 Jun; 43(4):416-422. PubMed ID: 29350409
[TBL] [Abstract][Full Text] [Related]
13. KIT masters mast cells in kids, too.
Kambe N; Longley BJ; Miyachi Y; Kabashima K
J Invest Dermatol; 2010 Mar; 130(3):648-50. PubMed ID: 20145643
[TBL] [Abstract][Full Text] [Related]
14. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
[TBL] [Abstract][Full Text] [Related]
15. The genetic basis of mast cell activation disease - looking through a glass darkly.
Molderings GJ
Crit Rev Oncol Hematol; 2015 Feb; 93(2):75-89. PubMed ID: 25305106
[TBL] [Abstract][Full Text] [Related]
16. Kit Mutations: New Insights and Diagnostic Value.
Falchi L; Verstovsek S
Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460
[TBL] [Abstract][Full Text] [Related]
17. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
[TBL] [Abstract][Full Text] [Related]
18. CD1a-positive familial cutaneous mastocytosis without germ-line or somatic mutations in c-kit.
Arase N; Wataya-Kaneda M; Oiso N; Arase H; Katayama I
Br J Dermatol; 2013 Jul; 169(1):201-4. PubMed ID: 23834123
[No Abstract] [Full Text] [Related]
19. A case of childhood-onset cutaneous mastocytosis with loss of wild-type KIT allele.
Hida T; Okura M; Kamiya T; Yamamoto M; Hori T; Uhara H
J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):e235-e237. PubMed ID: 30773694
[No Abstract] [Full Text] [Related]
20. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.
Akin C; Kirshenbaum AS; Semere T; Worobec AS; Scott LM; Metcalfe DD
Exp Hematol; 2000 Feb; 28(2):140-7. PubMed ID: 10706069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
